Roivant Sciences Ltd. (ROIV)
29.06
+0.56
(+1.98%)
USD |
NASDAQ |
Jun 09, 16:00
29.06
0.00 (0.00%)
After-Hours: 20:00
Roivant Sciences Total Assets (Quarterly) : 5.728B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Centessa Pharmaceuticals Plc | 641.76M |
| Aptorum Group Ltd. | 18.69M |
| Bicycle Therapeutics Plc | 652.40M |
| Adaptimmune Therapeutics Plc | 130.63M |
| Kiniksa Pharmaceuticals International Plc | 825.28M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 435.63M |
| Shareholders Equity (Quarterly) | 4.527B |
| Debt to Equity Ratio | 0.0237 |
| Current Ratio | 18.37 |
| Net Debt Paydown Yield | -0.01% |